HealthCarePoint Establishes BlueCloud India, Connecting the Industry to Ensure Privacy, Research Readiness and GCP Compliance

BlueCloud India will use interconnectivity to improve healthcare and clinical research to benefit industry stakeholders and patients of the region.

BlueCloud by HealthCarePoint (HCP) has expanded to India, with strategic partnership with Clinexel Life Sciences Pvt Ltd. India is one of the fastest growing healthcare sectors in the world. BlueCloud India will use BlueCloud networking systems to deliver, distribute, implement and track (DDIT™)business and compliance programs and initiatives with investigative sites, sponsors and CROs to improve clinical research readiness and GCP compliance.

Strategic partnership with CLINEXEL Life Sciences, provider of scientific support and services to pharma, and other industry stakeholders, will be implementing BlueCloud technologies into sites and site networks in India, where the healthcare market is expected to reach $372 billion annually by 2022, according to – The Economic Times. With local access to these technologies, India’s research and healthcare organizations can improve educational opportunities and market visibility for clinical practitioners and quality of life for patients. Indian and regional members also will be able to more efficiently deliver, distribute, implement and track their clinical research business and compliance programs and initiatives using an interconnected global network of 1.6 million healthcare professionals from thousands of healthcare and clinical research organizations.

The Indian expansion will complement BlueCloud’s networking systems in the US, Puerto Rico, Central and South America, Europe, Australia, Asia and Africa – providing real-time connectivity between sites, sponsors and CROs in a private, GDPR and CCPA compliant environment. This global connectivity:

  • Improves productivity and sustainability by connecting investigative sites with international sponsors, CROs and universities to exchange professional and site-specific information, offer real-time site screening, improve study start-up and increase study pipelines;
  • Minimizes potential fraud and abuse via real-time third-party verification of investigator sites, reassuring sponsors, universities and regulatory agencies that investigator site competencies are being achieved; and
  • Improves the ability to meet regulatory privacy standards by offering healthcare and clinical research professionals personal BlueCloud accounts where they can access necessary protocol, training, career certifications and globally accepted standards of care from one centralized, globally accessible location. Professionals and management can also electronically share these documents for the purposes of demonstrating competencies.

Sites, sponsors and CROs will have real-time access to the global BlueCloud Education Network and its providers of standards training and certification programs that professionals use to further their educational activities for competency documentation for regulatory requirements and certification for patient based diagnostics tools and subject recruitment standards required in clinical trials.

BlueCloud’s technological capabilities are continuously expanding, increasing visibility and opportunities for service providers, professionals and consumers. Ultimately, the goal of BlueCloud India and BlueCloud networks worldwide is to make outstanding healthcare available to patients in even remote communities by improving healthcare and clinical research and expediting the product-to-market development process.

“BlueCloud will help enhance medical research and innovation in India via a global connectivity,” says Dr. Deepa Arora, Founder Director of CLINEXEL Life Sciences Private Limited. “We are excited about this strategic partnership. Patients will benefit from improved clinical researcher training and provider networking capabilities.”

“This is an important step to enhancing clinical research activities for the global (bio-) pharmaceutical and medical device industry in India,” says Heike Schoen, managing director of Lumis International GmbH, member of the scientific Advisory Board of BlueCloud, and former 2010-2011 Association of Clinical Research Professionals (ACRP) Chair. “By simplifying and encouraging cooperation between hospitals and clinical sites, the region can maintain the highest clinical research standards and provide early patient access to innovative medications.”

Al O. Pacino, president and co-founder of BlueCloud by HealthCarePoint explained, “BlueCloud DDIT mechanisms and quality management systems are essential for BlueCloud India to bring never-before tracking capabilities such as care standards to hospitals, clinical practices, research facilities, regulators and sponsors to eliminate redundancies and ultimately eliminate fraud and abuse – ultimately minimizing data variability in clinical trials”.

“There is a global need for industry stakeholders to maintain compliance expectations and deliver necessary training, protocols and information in a modern, yet cost-efficient, way. BlueCloud improves existing systems while saving more lives.”

About CLINEXEL Life Sciences Private Limited
CLINEXEL is scientific process organization providing scientific support and services to pharma industry and research organizations. We provide services to pharma, biotech and medical device companies in clinical development, medical affairs, pharmacovigilance and clinical research. We are committed for quality and speed in clinical research by developing a network of sites with performance and efficiencies matching the GCP compliance needs and targeting therapeutic gaps where medical innovation is most desirable. By leveraging strategic partnerships and establishing world-class capabilities in line with sponsors’ needs, requirements and preferences along with a hands-on relationship with research sites, we will make for a successful initiative.

About BlueCloud by HealthCarePoint
A global sustainable innovation providing delivery, distribution and implementation (DDI) mechanisms for all industry stakeholders, BlueCloud is a Connector Service Provider (CSP®). Nominated as one of the top innovations in the industry, BlueCloud is the first independent (real-time / single sign-on) professional network for healthcare and clinical research. This global collaborative network connects all stakeholders in a secure, regulated, private system that ultimately ensures human subject protection by tracking business and compliance processes. BlueCloud is now used in more than 167 countries by more than 1.6 million healthcare professionals from thousands of organizations including sponsors, CROs, research sites, hospitals, universities, and other healthcare and clinical research stakeholders that use its applications to connect, organize, centralize and share verifiable information in real-time for managerial and compliance activities. The network is proven to save the industry millions of dollars by eliminating redundancies, expediting study start up and ensuring quality, transparency and compliance – modernizing the industry through connectivity and creating a system that leaves no patient behind regardless of religion, race or social status worldwide.


There are no upcoming events.